CTLA4 and nonpapillary renal cell carcinoma: These results indicate that HAMP and immune checkpoint genes (PDCD1, LAG3, TIGIT, and CTLA4) were coordinately upregulated in ccRCC tissues with a strong clinical impact on patient survival outcomes.